MADRIGAL PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

MADRIGAL PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $12.85 (loss) per share for the year ending 2025.

  • MADRIGAL PHARMACEUTICALS, INC. showed an increase of +41.3% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from MADRIGAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2009 to 2025), MADRIGAL PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has declined by 653.9%.
  • Historical annual values: Fiscal year 2025: $12.85 (loss) per share | Fiscal year 2024: $21.90 (loss) per share | Fiscal year 2023: $19.99 (loss) per share | Fiscal year 2022: $17.23 (loss) per share | Fiscal year 2021: $14.63 (loss) per share | Fiscal year 2020: $13.09 (loss) per share | Fiscal year 2011: $1.00 (loss) per share | Fiscal year 2010: $0.93 (loss) per share | Fiscal year 2009: $2.32 per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: